Physician profile
Hussein Othman
NPI 1306089040
$8,187.20
in general payments reported to CMS, 2019-2025
42 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $442 · 2021: $1,540 · 2022: $1,543 · 2023: $1,900 · 2024: $1,372 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,423.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,500.06 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,091.06 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $658.85 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $468.35 | 2021-2025 | Verquvo |
| Philips North America LLC | $414.08 | 2022-2025 | (Ck4) Mcot, Ecc Solutions |
| Pfizer INC. | $388.43 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.38 | 2021-2025 | Jardiance |
| Abbott Laboratories | $276.17 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre 3 |
| Boston Scientific Corporation | $264.19 | 2021-2024 | Varithena Administration Pack, Eluvia |
| Astrazeneca Pharmaceuticals Lp | $261.66 | 2020-2024 | Brilinta, Farxiga |
| Shockwave Medical, INC | $231.15 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $231.02 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sanofi-Aventis U.S. LLC | $227.78 | 2019-2023 | |
| Amarin Pharma, INC. | $183.87 | 2020-2021 | |
| Astellas Pharma US INC | $158.99 | 2021-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $134.05 | 2020-2025 | Repatha |
| Esperion Therapeutics, INC. | $130.54 | 2020-2024 | Nexletol |
| Terumo Medical Corporation | $116.05 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $105.80 | 2022-2025 | Opsumit, Uptravi |
| Novo Nordisk INC | $87.57 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Chiesi USA, INC. | $80.00 | 2019-2024 | Kengreal |
| Tactile Systems Technology INC | $79.47 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abiomed | $76.90 | 2019-2025 | Impella |
| Kiniksa Pharmaceuticals International, Plc | $66.45 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $65.45 | 2025 | |
| Medtronic, INC. | $63.11 | 2022-2025 | Hawkone, Corevalve Evolut R |
| Alnylam Pharmaceuticals INC. | $51.63 | 2023-2025 | Amvuttra, Onpattro |
| Lexicon Pharmaceuticals, INC. | $45.44 | 2023 | Inpefa |
| Baxter Healthcare | $41.78 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Penumbra, INC. | $39.85 | 2023 | Indigo System, Ruby Coil |
| Portola Pharmaceuticals, LLC | $39.69 | 2019 | |
| Kiniksa Pharmaceuticals, Ltd. | $35.79 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $33.32 | 2025 | Optowire |
| Inspire Medical Systems, INC. | $23.81 | 2024 | Inspire |
| Bridgebio Pharma, INC. | $22.94 | 2025 | Attruby |
| Ethicon US, LLC | $20.40 | 2025 | Surgiflo Hemostatic Matrix |
| Preventice Services, LLC | $18.87 | 2021 | |
| Teleflex LLC | $16.69 | 2025 | Turnpike |
| Bardy Diagnostics, INC. | $15.35 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $14.72 | 2023 | Lifevest |
| Corcept Therapeutics | $14.45 | 2025 | Korlym |
| Reflow Medical INC | $11.04 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hussein Othman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.